Metabolism of N-acetylbenzidine and initiation of bladder cancer

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 506-507, Issue , 2002, Pages 29-40

  Zenser, Terry V ^a   Lakshmi, Vijaya M ^a   Hsu, Fong Fu ^b   Davis, Bernard B ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Acetylation; Aromatic amines; Benzidine; Bladder cancer; Glucuronidation; N Acetylbenzidine; Peroxidation

Indexed keywords

ACID; BENZIDINE; BENZIDINE DERIVATIVE; CYTOCHROME P450; GLUCURONIDE; N ACETYL N' HYDROXYBENZIDINE; N ACETYLBENZIDINE; N,N' DIACETYLBENZIDINE; O GLUCURONIDE; PEROXIDASE; PROSTAGLANDIN SYNTHASE; REACTIVE NITROGEN SPECIES; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE DIPHOSPHATE GLUCORONOSYLTRANSFERASE; URIDINE DIPHOSPHATE GLUCORONOSYLTRANSFERASE 1A1; URIDINE DIPHOSPHATE GLUCORONOSYLTRANSFERASE 1A4; URIDINE DIPHOSPHATE GLUCORONOSYLTRANSFERASE 1A6; URIDINE DIPHOSPHATE GLUCORONOSYLTRANSFERASE 1A9; URIDINE DIPHOSPHATE GLUCORONOSYLTRANSFERASE 2B7;

ACETYLATION; ARTICLE; BLADDER CANCER; BLADDER EPITHELIUM; CARCINOGENESIS; CELL; DEACETYLATION; ENZYME ACTIVITY; HORSERADISH; HUMAN; LIVER; METABOLISM; NONHUMAN; OCCUPATIONAL EXPOSURE; OXIDATION; PRIORITY JOURNAL; URINE; URINE PH;

ACETYLATION; ANIMALS; BENZIDINES; CARCINOGENS; CYTOCHROME P-450 ENZYME SYSTEM; DNA ADDUCTS; GLUCURONATES; HUMANS; HYDROGEN-ION CONCENTRATION; MICROSOMES, LIVER; REACTIVE OXYGEN SPECIES; URINARY BLADDER NEOPLASMS;

ARMORACIA RUSTICANA;

EID: 18344397488     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(02)00149-5     Document Type: Article

References (83)

1. Rehn L. Blasengeschwulste bei fuchsinarbeitern. Arch. Klin. Chir. 50:1895;588-600.
2. Case R.A.M., Hosker M.W., McDonald D.B., Pearson J.T. Tumors of the urinary bladder in workmen engaged in the manufacture use of certain dyestuff intermediates in the British chemical industry. Br. J. Ind. Med. 11:1954;75-104.
3. R. Doll, R. Peto, The Causes of Cancer, Oxford University Press, New York, 1981.
4. Bi W., Hayes R.B., Feng P., Qi Y., You X., Zhen J., Zhang M., Qu B., Fu Z., Chen M., Chien H.T.C., Blot W.J. Mortality and incidence of bladder cancer in benzidine-exposed workers in China. Am. J. Ind. Med. 21:1992;481-489.
5. Silverberg E., Lubera J. Cancer statistics. Cancer J. Clin. 37:1987;2-19.
6. Parker S.L., Tong T., Bolden S., Wingo P. Cancer statistics. Cancer J. Clin. 46:1996;5-27.
7. Haley T.J. Benzidine revisited: a review of the literature and problems associated with the use of benzidine and its congeners. Clin. Toxicol. 8:1975;13-42.
8. Radomski J.L. The primary aromatic amines: their biological properties and structure-activity relationships. Annu. Rev. Pharmacol. Toxicol. 19:1979;129-157.
9. Lower G.M. Jr., Bryan G.T. Enzymatic N-acetylation of carcinogenic aromatic amines by liver cytosol of species displaying different organ susceptibilities. Biochem. Pharmacol. 22:1973;1581-1588.
10. Poirier L.A., Miller J.A., Miller E.C. The N- and ring-hydroxylation of 2-acetylaminofluorene and the failure to detect N-acetylation of 2-aminofluorene in the dog. Cancer Res. 23:1963;790-800.
11. Grant D.M., Blum M., Beer M., Meyer U.A. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Mol. Pharmacol. 39:1991;184-191.
12. Ohsako S., Deguchi T. Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. J. Biol. Chem. 265:1990;4630-4634.
13. Weber W.W., Hein D.W. N-Acetylation pharmacogenetics. Pharmacol. Rev. 37:1985;25-79.
14. Blum M., Demierre A., Grant D.M., Heim M., Meyer U.A. Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc. Natl. Acad. Sci. U.S.A. 88:1991;5237-5241.
15. Deguchi T., Mashimo M., Suzuki T. Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. J. Biol. Chem. 265:1990;12757-12760.
16. Vatsis K.P., Weber W.W. Structural heterogeneity of caucasian N-acetyltransferase at the NAT1 locus. Arch. Biochem. Biophys. 301:1993;71-76.
17. *10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res. 55:1995;5226-5229.
18. Hein D.W. Acetylator genotype and arylamine-induced carcinogenesis. Biochim. Biophys. Acta. 948:1988;37-66.
19. Hayes R.B., Bi W., Rothman N., Broly F., Caporaso N., Feng P., You X., Yin S., Woosley R., Meyer U.A. N-Acetylation phenotype and genotype and risk of bladder cancer, in benzidine-exposed workers. Carcinogenesis. 14:1993;675-678.
20. Zenser T.V., Lakshmi V.M., Rustan T.D., Doll M.A., Deitz A.C., Davis B.B., Hein D.W. Human N-acetylation of benzidine: role of NAT1 and NAT2. Cancer Res. 56:1996;3941-3947.
21. Lakshmi V.M., Bell D.A., Watson M.A., Zenser T.V., Davis B.B. N-Acetylbenzidine and N,N′-diacetylbenzidine formation by rat and human liver slices exposed to benzidine. Carcinogenesis. 16:1995;1565-1571.
22. Rothman N., Bhatnagar V.K., Hayes R.B., Zenser T.V., Kashyap S.K., Butler M.A., Bell D.A., Lakshmi V., Jaeger M., Kashyap R., Hirvonen A., Schulte P.A., Dosemeci M., Hsu F., Parikh D.J., Davis B.B., Talaska G. The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5084-5089.
23. G.J. Dutton, Glucuronidation of Drugs and Other Compounds, CRC Press, Boca Raton, FL, 1980, pp. 1-78.
24. G.J. Mulder, M.W.H. Coughtrie, B. Burchell, Glucuronidation, in: G.J. Mulder (Ed.), Conjugation Reactions in Drug Metabolism: An Integrated Approach, Taylor & Francis, New York, 1990, pp. 51-105.
25. Burchell B., Nebert D.W., Nelson D.R., Bock K.W., Iyanagi T., Jansen P.M., Lancet D., Mulder G.J., Chowdhury J.R., Siest G., Tephly T.R., Mackenzie P.I. The UDP-glucuronosyltransferase gene superfamily: suggested nomenclature based on envolutionary divergence. DNA Cell Biol. 10:1991;487-494.
26. Munzel P.A., Bookjans G., Mehner G., Lehmkoster T., Bock K.W. Tissue-specific 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible expression of human UDP-glucuronosyltransferase UGT1A6. Arch. Biochem. Biophys. 335:1996;205-210.
27. Ritter J.K., Sheen Y.Y., Owens I.S. Cloning and expression of human liver UDP-glucuronosyltransferase in COS-1 cells. J. Biol. Chem. 265:1990;7900-7906.
28. Jin C., Miners J.O., Lillywhite K.J., Mackenzie P.I. Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. J. Pharmacol. Exp. Ther. 264:1993;475-479.
29. Ciotti M., Marrone A., Potter C., Owens I.S. Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics. 7:1997;485-495.
30. Babu S.R., Lakshmi V.M., Owens I.S., Zenser T.V., Davis B.B. Human liver glucuronidation of benzidine. Carcinogenesis. 15:1994;2003-2007.
31. Green M.D., Bishop W.P., Tephly T.R. Expressed human UGT1.4 protein catalyzes the formation of quaternary ammonium-linked glucuronides. Drug Metab. Dispos. 23:1995;299-302.
32. Babu S.R., Lakshmi V.M., Hsu F.F., Kane K.E. III, Zenser T.V., Davis B.B. N-Acetylbenzidine-N′-glucuronidation by human, dog, and rat liver. Carcinogenesis. 14:1993;2605-2611.
33. Babu S.R., Lakshmi V.M., Zenser T.V., Davis B.B. Glucuronidation of N-acetylbenzidine by human liver. Drug Metab. Dispos. 22:1994;922-927.
34. Babu S.R., Lakshmi V.M., Hsu F.F., Zenser T.V., Davis B.B. Role of N-glucuronidation in benzidine-induced bladder cancer in dog. Carcinogenesis. 13:1992;1235-1240.
35. Lakshmi V.M., Zenser T.V., Goldman H.D., Spencer G.G., Gupta R.C., Hsu F.F., Davis B.B. The role of acetylation in benzidine metabolism and DNA adduct formation in dog and rat liver. Chem. Res. Toxicol. 8:1995;711-720.
36. Kadlubar F.F., Miller J.A., Miller E.C. Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. Cancer Res. 37:1977;805-814.
37. Babu S.R., Lakshmi V.M., Hsu F.F., Zenser T.V., Davis B.B. Glucuronidation of N-hydroxy metabolites of N-acetylbenzidine. Carcinogenesis. 16:1995;3069-3074.
38. Ciotti M., Lakshmi V.M., Basu N., Davis B.B., Owens I.S., Zenser T.V. Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferases and pH stability of glucuronides. Carcinogenesis. 20:1999;1963-1969.
39. Babu S.R., Lakshmi V.M., Huang G.P.-W., Zenser T.V., Davis B.B. Glucuronide conjugates of 4-aminobiphenyl and its N-hydroxy metabolites: pH stability and synthesis by human and dog liver. Biochem. Pharmacol. 51:1996;1679-1687.
40. Gonick H.C., Kramer H.J., Schapiro A.E. Urinary β-glucuronidase activity in renal disease. Arch. Int. Med. 132:1973;63-69.
41. Zenser T.V., Lakshmi V.M., Davis B.B. Human and E. coli glucuronidase hydrolysis of glucuronide conjugates of benzidine and 4-aminobiphenyl, and their hydroxy metabolites. Drug Metab. Dispos. 27:1999;1064-1067.
42. Glaser J.H., Sly W.S. β-Glucuronidase deficiency mucopolysaccharidosis: methods for enzymatic diagnosis. J. Lab. Clin. Med. 82:1973;969-977.
43. Harris R.E., Thomas V.L., Underwood J.M., Gaudot F. A comparison of two indirect methods for localizing the site of urinary infection: beta glucuronidase levels and the presence of antibody-coated bacteria. Am. J. Obstet. Gynecol. 131:1978;647-649.
44. Rothman N., Talaska G., Hayes R., Bhatnagar V., Bell D., Lakshmi V., Kashyap S., Dosemeci M., Kashyap R., Hsu F., Jaeger M., Hirvonen A., Parikh D., Davis B., Zenser T. Acidic urine pH is associated with elevated levels of free urinary benzidine and N-acetylbenzidine and urothelial cell DNA adducts in exposed workers. Cancer Epidemiol. Biomarkers Prev. 6:1997;1039-1042.
45. Poulsen L.L., Taylor K., Williams D.E., Siler-Masters B.S., Ziegler D.M. Substrate specificity of the rabbit lung flavin-containing monooxygenase for amines: oxidation products of primary alkylamines. Mol. Pharmacol. 30:1986;680-685.
46. Lakshmi V.M., Zenser N.T., Hsu F.F., Mattammal M.B., Zenser T.V., Davis B.B. NADPH-dependent oxidation of benzidine by rat liver. Carcinogenesis. 17:1996;1941-1947.
47. Butler M.A., Guengerich F.P., Kadlubar F.F. Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4′-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases. Cancer Res. 49:1989;25-31.
48. Lakshmi V.M., Zenser T.V., Davis B.B. Rat liver cytochrome P-450 metabolism of N-acetylbenzidine and N,N′-diacetylbenzidine. Drug Metab. Dispos. 25:1997;481-488.
49. Martin C.N., Beland F.A., Roth R.W., Kadlubar F.F. Covalent binding of benzidine and N-acetylbenzidine to DNA at the C-8 atom of deoxyguanosine in vivo and in vitro. Cancer Res. 42:1982;2678-2686.
50. Wise R.W., Zenser T.V., Kadlubar F.F., Davis B.B. Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase. Cancer Res. 44:1984;1893-1897.
51. Danon A., Zenser T.V., Thomasson D.L., Davis B.B. Eicosanoid synthesis by cultured human urothelial cells: potential role in bladder cancer. Cancer Res. 46:1986;5676-5681.
52. 2 levels of human urothelial cells. Carcinogenesis. 9:1988;1173-1177.
53. 2 synthesis. Carcinogenesis. 10:1989;1621-1627.
54. Zenser T.V., Eling T.E., Duniec Z.M., Wong Y.-H.H., Davis B.B. Mechanism of 12-0-tetradecanoylphorbol-13-acetate enhanced metabolism of arachidonic acid in dog urothelial cells. Cancer Res. 50:1990;4650-4655.
55. Flammang T.J., Yamazoe Y., Benson R.W., Roberts D.W., Potter D.W., Chu D.Z.J., Lang N.P., Kadlubar F.F. Arachidonic acid-dependent peroxidative activation of carcinogenic arylamines by extrahepatic human tissue microsomes. Cancer Res. 49:1989;1977-1982.
56. Wise R.W., Zenser T.V., Davis B.B. Prostaglandin H synthase oxidation of benzidine and o-dianisidine: reduction and conjugation of activated amines by thiols. Carcinogenesis. 6:1985;579-583.
57. Wise R.W., Zenser T.V., Rice J.R., Davis B.B. Peroxidatic metabolism of benzidine by intact tissue: a prostaglandin H synthase-mediated process. Carcinogenesis. 7:1986;111-115.
58. Yamazoe Y., Miller D.W., Weis C.C., Dooley K.L., Zenser T.V., Beland F.A., Kadlubar F.F. DNA adducts formed by ring-oxidation of the carcinogen 2-naphthylamine with prostaglandin H synthase in vitro and in the dog urothelium in vivo. Carcinogenesis. 6:1985;1379-1387.
59. Yamazoe Y., Zenser T.V., Miller D.W., Kadlubar F.F. Mechanism of formation and structural characterization of DNA adducts derived from peroxidative activation of benzidine. Carcinogenesis. 9:1988;1635-1641.
60. Wise R.W., Z enser T.V., Davis B.B. Prostaglandin H synthase metabolism of the urinary bladder carcinogens benzidine and ANFT. Carcinogenesis. 4:1983;285-289.
61. Zenser T.V., Mattammal M.B., Wise R.W., Rice J.R., Davis B.B. Prostaglandin H synthase-catalyzed activation of benzidine: a model to assess pharmacologic intervention of the initiation of chemical carcinogenesis. J. Pharmacol. Exp. Ther. 227:1983;545-550.
62. Josephy P.D., Eling T.E., Mason R.P. An electron spin resonance study of the activation of benzidine by peroxidases. Mol. Pharmacol. 23:1983;766-770.
63. Yamazoe Y., Roth R.W., Kadlubar F.F. Reactivity of benzidine diimine with DNA to form N-(deoxyguanosin-8-yl)-benzidine. Carcinogenesis. 7:1986;179-182.
64. Zhou Q., Talaska G., Jaeger M., Bhatnagar V.K., Hayes R.B., Zenser T.V., Kashyap S.K., Lakshmi V.M., Kashyap R., Dosemeci M., Hsu F.F., Parikh D.J., Davis B., Rothman N. Benzidine-DNA adduct levels in human peripheral white blood cells significantly correlate with levels in exfoliated urothelial cells. Mutat. Res. 393:1997;199-205.
65. Lakshmi V.M., Zenser T.V., Davis B.B. N′-(3′-Monophospho-deoxyguanosin-8-yl)-N-acetylbenzidine formation by peroxidative metabolism. Carcinogenesis. 19:1998;911-917.
66. Zenser T.V., Lakshmi V.M., Hsu F.F., Davis B.B. Peroxygenase metabolism of N-acetylbenzidine by prostaglandin H synthase. J. Biol. Chem. 274:1999;14850-14856.
67. Smith B.J., DeBruin L., Josephy D., Eling T.E. Mutagenic activation of benzidine requires prior bacterial acetylation and subsequent conversion by prostaglandin H synthase to 4-nitro-4′-(acetylamino)biphenyl. Chem. Res. Toxicol. 5:1992;431-439.
68. Kennelly J.C., Beland F.A., Kadlubar F.F., Martin C.N. Binding of N-acetylbenzidine and N,N′-diacetylbenzidine to hepatic DNA of rat and hamster in vivo and in vitro. Carcinogenesis. 5:1984;407-412.
69. Beland F.A., Beranek D.T., Dooley K.L., Heflich R.H., Kadlubar F.F. Arylamine-DNA adducts in vitro and in vivo: their role in bacterial mutagenesis and urinary bladder carcinogenesis. Environ. Health Perspect. 49:1983;125-134.
70. Melchior W.B., Marques M.M. Jr., Beland F.A. Mutations induced by aromatic amine DNA adducts in pBR322. Carcinogenesis. 15:1994;889-899.
71. Heflich R.H., Morris S.M., Beranek D.T., McGarrity L.J., Chen J.J., Beland F.A. Relationships between the DNA adducts and the mutations and sister chromatid exchanges produced in Chinese hamster ovary cells by N-hydroxy-2-aminofluorene, N-hydroxy-N′-acetylbenzidine and 1-nitrosopyrene. Mutagenesis. 1:1986;201-206.
72. Fox T.R., Schumann A.M., Watanabe P.G., Yano B.L., Maher V.M., McCormick J.J. Mutational analysis of the H-ras oncogene in spontaneous C57BL/6 × C3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens. Cancer Res. 50:1990;4014-4019.
73. Lakshmi V.M., Hsu F.F., Davis B.B., Zenser T.V. N-Acetylbenzidine-DNA adduct formation by phorbol 12-myristate stimulated human polymorphonuclear neutrophils. Chem. Res. Toxicol. 13:2000;785-792.
74. Lakshmi V.M., Hsu F.F., McGarry A.E., Davis B.B., Zenser T.V. Hypochlorous acid-mediated activation of N-acetylbenzidine to form N′-(3′-monophospho-deoxyguanosin-8-yl)-N-acetylbenzidine. Toxicol. Sci. 53:2000;202-212.
75. Hsu F.F., Lakshmi V., Rothman N., Bhatnager V.K., Hayes R.B., Kashyap R., Parikh D.J., Kashyap S.K., Turk J., Zenser T., Davis B. Determination of benzidine, N-acetylbenzidine and N,N′-diacetylbenzidine in human urine by capillary gas chromatography/negative ion chemical ionization mass spectrometry. Anal. Biochem. 234:1996;183-189.
76. Lakshmi V.M., Hsu F.F., Davis B.B., Zenser T.V. Sulfinamide formation following peroxidatic metabolism of N-acetylbenzidine. Chem. Res. Toxicol. 13:2000;96-102.
77. Lakshmi V.M., Hsu F.F., Davis B.B., Zenser T.V. Methemoglobin oxidation of N-acetylbenzidine to form a sulfinamide. Drug Metab. Dispos. 29:2001;401-406.
78. Lakshmi V.M., Zenser T.V., Davis B.B. Mechanism of 3-(glutathion-S-yl)-benzidine formation. Toxicol. Appl. Pharmacol. 125:1994;256-263.
79. J. Parsonnet, Microbes and Malignancy. Infection as a Cause of Human Cancer, Oxford University Press, New York, 1999.
80. Lakshmi V.M., Hsu F.F., Davis B.B., Zenser T.V. Reactive nitrogen oxygen species metabolize N-acetylbenzidine. Chem. Res. Toxicol. 14:2001;312-318.
81. Grisham M.B., Jourd'Heuil D., Wink D.A. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am. J. Physiol. 39:1999;G315-G321.
82. Bejany D.E., Lockhart J.L., Rhamy R.K. Malignant vesical tumors following spinal cord injury. J. Urol. 138:1987;1390-1392.
83. I. El-Sebai. Carcinoma of urinary bladder in Egypt: current clinical experience, in: M.N. El-Bolkainy, E.W. Chu (Eds.), Detection of Bladder Cancer Associated with Schistosomiasis, The National Cancer Institute, Cairo University, Al-Ahram Press, Cairo, 1981, pp. 9-18.